← Back to CHRS

Coherus Oncology, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 05/08/2026Mar 2026Filed 05/08/2026Sep 2025Filed 06/11/2025Jun 2025Filed 05/08/2026Mar 2025Filed 05/08/2026Sep 2024Filed 06/11/2025Jun 2024Filed 06/11/2025Mar 2024Filed 06/11/2025
$14$12$12$10$7.6$6.1$10$2.3
−$21−$38−$36$298−$57−$11−$13$103
−$0.13−$0.28−$0.31$2.57$2.57−$0.09−$0.11$0.91
155136116116116115115113

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.